Skip to main content

Advertisement

SpringerLink
Log in

MR imaging of the breast: indications, established technique, and new directions

  • Contrast Optimization in MRI
  • Published:
European Radiology Aims and scope Submit manuscript

Conclusion

In summary, Gd-enhanced dynamic MR imaging is an established, highly sensitive technique for studying breast cancer in well-defined situations. The role of breast MR imaging will increase over the next few years. Advances in both technique (high temporal/spatial resolution) and contrast agents (high T1-relaxivity Gd-chelates, as well as blood-pool agents and lymph-nodetargeted agents) should increase sensitivity and specifity. Proton MR spectroscopy may add further possibilities for the characterization of lesions.

It remains to be seen how these new directions, combined with future developments in hardware (e.g., breast-dedicated MR equipment), will impact on the future of MR imaging of the breast.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Heywang SH (1988) MRI does not replace mammography—present state of MRI of the breast without contrast agent. J Med Imaging 8:817–826

    Google Scholar 

  2. Sardanelli F, Satragno L, Ottonello C, et al (1991) MRI signal and morphologic criteria with pathologic correlations in breast tumors. Abstracts 8th Congress European Society for Magnetic Resonance in Medicine and Biology, Zürich, Switzerland, April 18–21, 1991:305

  3. Heywang SH, Hahn D, Schmidt H, et al (1986) MRI of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199–204

    Article  CAS  PubMed  Google Scholar 

  4. Heywang-Kobrunner SH, Beck R (1995) Contrast-enhanced MRI of the breast, 2nd edn. Springer-Verlag, Berlin

    Google Scholar 

  5. Morakkabati N, Leutner CC, Schmiedel A, Boldt I, Kuhl CK (1999) Breast MR imaging in patients during or soon after radiotherapy: How significant are radiation-induced changes, and do they interfere with diagnostic accuracy? Radiology 213(P):455

    Google Scholar 

  6. Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM (2000) MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol 175:1577–1584

    CAS  PubMed  Google Scholar 

  7. Orel SG, Schnall MD, Powell CM, et al (1995) Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy. Radiology 196:115–122

    CAS  PubMed  Google Scholar 

  8. Boné B, Aspelin P, Bronge L, Isberg B, Perbeck L, Veress B (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208–213

    Article  PubMed  Google Scholar 

  9. Heywang-Kobrunner SH, Viehweg P, Heinig A, Küchler C (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94–108

    Article  CAS  PubMed  Google Scholar 

  10. Del Maschio A, Panizza P (1998) Breast MR: state of the art. Eur J Radiol 27:250–253

    Article  Google Scholar 

  11. Fischer U, Westerhof JP, Brinck U, Korabiowska M, Schauer A, Grabbe E (1996) Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T. ROFO 164:290–294

    CAS  PubMed  Google Scholar 

  12. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of the preoperative contrast enhanced MR imaging on the therapeutic approach. Radiology 231:881–888

    Google Scholar 

  13. Malur S, Wurdinger S, Moritz A, Michels W, Schneider A (2001) Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res 3:55–60

    Article  CAS  PubMed  Google Scholar 

  14. Nunes LW, Schnall MD, Orel SG, et al (1997) Breast MR imaging: interpretation model. Radiology 202:833–841

    CAS  PubMed  Google Scholar 

  15. Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087–1092

    Article  CAS  PubMed  Google Scholar 

  16. Hlawatsch A, Teifke A, Schmidt M, Thelen M (2002) Preoperative assessment of breast cancer: Sonography versus MR imaging. AJR Am J Roentgenol 179:1493–1501

    PubMed  Google Scholar 

  17. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193–1199

    PubMed  Google Scholar 

  18. Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E (1999) MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 9:470–473

    Article  CAS  PubMed  Google Scholar 

  19. Podo F, Sardanelli F, Canese R, D'Agnolo G, Natali PG, et al (2002) The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Canc Res 21 [Suppl]:115–124

    CAS  Google Scholar 

  20. Sardanelli F, Giuseppetti GM, Bazzocchi M, Simonetti G, Lattanzio V, Del Maschio A (2002) Looking for multifocal/multicentric breast cancer in 99 mastectomies: a multicenter trial on Gd-enhanced breast MR versus X-ray mammography. A breast by-breast analysis. Radiology 225(P):651

    Google Scholar 

  21. Sardanelli F, Iozzelli A, Fausto A (2002) Contrast agents and temporal resolution in breast MR imaging. J Exp Clin Canc Res 21 [Suppl]:69–75

    CAS  Google Scholar 

  22. Sardanelli F, Calabrese M, Zandrino F, et al (1998) Dynamic helical CT of breast tumors. J Comput Assist Tomogr 22:398–407

    Article  CAS  PubMed  Google Scholar 

  23. Lauffer RB (1990) Magnetic resonance contrast media: principles and progress. Magn Reson Q 6:65–84

    CAS  PubMed  Google Scholar 

  24. Niendorf HP, Alhassan A, Geens VR, Clauss W (1994) Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications. Invest Radiol 29 [Suppl 2]:S179–82

    Article  Google Scholar 

  25. De Ridder F, De Maeseneer M, Stadnik T, Luypaert R, Osteaux M (2001) Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations. JBR-BTR 84:150–152

    PubMed  Google Scholar 

  26. Okada S, Katagiri K, Kumazaki T, Yokoyama H (2001) Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiol 42:339–341

    Article  CAS  PubMed  Google Scholar 

  27. Haustein J, Laniado M, Niendorf HP, et al (1993) Tripledose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology 186:855–60

    CAS  PubMed  Google Scholar 

  28. Sardanelli F, Mancardi G, Filippi M (2003) Safety of the long-time monthly triple dose of a Gd-based contrast agent. Eur Radiol, DOI 10.1007/s00330-003-1830-y

  29. Papadimitriou JM, Woods AE (1975) Structural and functional characteristics of the microcirculation in neoplasms. J Pathol 116:65–72

    Article  Google Scholar 

  30. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis, correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    Article  CAS  PubMed  Google Scholar 

  31. Horak E, Leek R, Klenk N, et al (1992) Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120–1124

    Article  CAS  PubMed  Google Scholar 

  32. Bosari S, Lee A, De Lellis R, Wiley B, Heatley G, Silverman M (1992) Microvessel quantification and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761

    Article  CAS  PubMed  Google Scholar 

  33. Weidner N, Folkman J, Pozza F, et al (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875–1880

    Article  CAS  PubMed  Google Scholar 

  34. Boetes C, Barentsz JO, Mus RD, et al (1994) MR characterization of supicious breast lesions with a gadolinium-enhanced turbo-FLASH subtraction technique. Radiology 193:777–781

    CAS  PubMed  Google Scholar 

  35. Boetes C, Mus RD, Holland R, et al (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743–747

    CAS  PubMed  Google Scholar 

  36. Hulka CA, Smith BL, Sgroi DC, et al (1995) Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 197:33–38

    CAS  PubMed  Google Scholar 

  37. Hulka CA, Edmister WB, Smith BL, et al (1997) Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205:837–842

    CAS  PubMed  Google Scholar 

  38. Sardanelli F, Rescinito G, Giordano GD, Calabrese M, Parodi RC (2000) MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study. J Comput Assist Tomogr 24:724–731

    Article  CAS  PubMed  Google Scholar 

  39. Kvistad KA, Rydland J, Vainio J, et al (2000) Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology 216:545–553

    CAS  PubMed  Google Scholar 

  40. Morakkabati-Spitz N, Sondermann E, Leutner CC, Dchild HH, Kuhl CK (2002) Systematic intra-individual evaluation of the diagnostic value of an increased spatial resolution in dynamic breast MR imaging. Radiology 225(P):651

    Google Scholar 

  41. Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine. Acad Radiol 6:282–291

    Article  CAS  PubMed  Google Scholar 

  42. Kirchin MA, Pirovano G, Spinazzi A (1998) Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 33:798–809

    Article  CAS  PubMed  Google Scholar 

  43. Cavagna FM, Maggioni F, Castelli PM, et al (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780–796

    Article  CAS  PubMed  Google Scholar 

  44. Knopp MV, Bourne MW, Sardanelli F, et al (2003) Gadobenate dimeglumine in contrast-enhanced MR imaging of the breast: a dose response analysis and comparison with gadopentetate dimeglumine. Am J Roengenol (in press)

  45. Sardanelli F, Iozzelli A, Aliprandi A, Salerio I (2002) Breast vascular maps with Gd-enhanced MR imaging using different doses of Gd-BOPTA. Eur Radiol 12 [Suppl 1]:159

    Google Scholar 

  46. Sardanelli F, Iozzelli A, Aliprandi A, Salerio I (2002) Asymmetry of vascular maps obtained by Gd-BOPTA-enhanced breast MR-predictive for breast cancer? Eur Radiol 12 [Suppl 1]:159

    Google Scholar 

  47. van Dijke CF, Brasch RC, Roberts TPL, et al (1996) Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198:813–818

    PubMed  Google Scholar 

  48. Tardivon AA, Guinebretiere JM, Dromain C, Caillet H (2002) MR imaging of breast cancer with a new macro cyclic blood pool agent (P792): result of a clinical phase II trial. Eur Radiol 12 [Suppl 1]:158

    Google Scholar 

  49. Daldrup-Link HE, Kaiser A, Link TM, et al (2002) Quantification of breast tumor microvascular permeabilities with feruglose (Clariscan) enhanced MR-mammography: initial clinical trial. Eur Radiol 12 [Suppl 1]:158

    Google Scholar 

  50. Daldrup-Link He, Brasch RC (2003) Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13:354–365

    Google Scholar 

  51. Katz-Brull R, Lavin PT, Lenkinski RE (2002) Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 94:1197–1203

    CAS  PubMed  Google Scholar 

  52. Michel SC, Keller TM, Frohlich JM, et al (2002) Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225:527–536

    PubMed  Google Scholar 

  53. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N (2003) Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent. Acta Radiol 44:35–42

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diagnostic Imaging, Istituto Policlinico San Donato, San Donato Milanese, Milan, Italy

    F. Sardanelli, A. Iozzelli & A. Fausto

Authors
  1. F. Sardanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Iozzelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Fausto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sardanelli, F., Iozzelli, A. & Fausto, A. MR imaging of the breast: indications, established technique, and new directions. Eur Radiol 13 (Suppl 3), N28–N36 (2003). https://doi.org/10.1007/s00330-003-0004-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-003-0004-2

Keywords

Search

Navigation